![Matt Patterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matt Patterson
Chief Executive Officer at
Iris Medicine, Inc.
Profile
Matthew R.
Patterson was the founder of Astellas Gene Therapies, Inc. (2012) and held the title of Chairman & Chief Executive Officer from 2018 to 2020.
Current jobs include Executive Chairman & Chief Executive Officer at Iris Medicine, Inc. (2021), Executive Chairman at Addition Therapeutics, Inc., Executive Chairman at Remix Therapeutics, Inc. (2021), Director at Gilda's Club New York City, Inc. (2010), Director at Modis Therapeutics, Inc. (2018), and Venture Partner at SR One Capital Management LP.
Former jobs include President & Chief Executive Officer at Amicus Therapeutics, Inc. (2004-2010), Chairman at Alliance for Regenerative Medicine (2018-2020), Independent Director at 5:01 Acquisition Corp.
(2020-2022), Independent Director at Vor Biopharma, Inc. (2020-2025), Independent Director at Homology Medicines, Inc., Vice President-Commercial Planning at BioMarin Pharmaceutical, Inc. (1998-2004), Senior Associate-Regulatory Affairs at Genzyme Corp.
(1993-1998), and Entrepreneur-in-Residence at OrbiMed Advisors Private Equity.
Education includes an undergraduate degree from Bowdoin College (1993).
Matt Patterson active positions
| Companies | Position | Start |
|---|---|---|
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Director/Board Member | 01/01/2010 |
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for developing disease modifying therapies | Director/Board Member | 29/10/2018 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chairman | 16/03/2021 |
Iris Medicine, Inc.
 Iris Medicine, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Chief Executive Officer | 01/03/2021 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Former positions of Matt Patterson
| Companies | Position | End |
|---|---|---|
| VOR BIOPHARMA INC. | Chairman | 25/06/2025 |
| 501 ACQU | Director/Board Member | 01/10/2022 |
| AUDENTES THERAPEUTICS, INC. | Chief Executive Officer | 15/01/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Chairman | 01/01/2020 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Matt Patterson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Modis Therapeutics, Inc.
Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for developing disease modifying therapies | Commercial Services |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Iris Medicine, Inc.
Iris Medicine, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Matt Patterson
